Key result
Saphenous vein graft stenting improves intermediate-term outcomes and reduces restenosis compared with PTCA.
Why the study?
Management of patients with recurrent angina after CABG is challenging due to high risk of repeat surgery and limitations of PTCA in saphenous vein grafts.
Does stenting improve outcomes and reduce restenosis compared to PTCA in patients with recurrent angina after CABG?
Does stenting improve outcomes and reduce restenosis compared to PTCA in patients with recurrent angina after CABG?
Stenting of saphenous vein grafts is a feasible alternative to repeat CABG and offers lower restenosis rates and better intermediate outcomes than PTCA.
Answers are grounded in this paper and cite their sources.
Stenting may be preferable to PTCA in saphenous vein grafts; leaves open need for randomized trials versus repeat CABG.
Surgical revascularization enjoys tremendous technical advances and offers low mortality despite its invasive nature. The management of patients with recurrent angina after CABG presents a difficult problem. The risk of repeat CABG is two‐ to fourfold higher than initial CABG. In view of these problems, PTCA is a feasible alternative that prevents reoperation in a select group of patients. A high restenosis rate and poor long‐term clinical outcome offset the good immediate results with PTCA of SVGs. Stenting offers the same procedural success rate with the added benefit of a lower restenosis rate and thus better short‐ and intermediate‐term outcomes. Further randomized trials and long‐term studies are needed to clearly define the benefit of stenting in vein grafts.
No takes yet. Share an insight, caveat, or question.
CORDERO‐YORDAN et al. (1999) conducted a review in Recurrent angina after CABG. Stenting vs. PTCA was evaluated. Stenting of saphenous vein grafts offers similar procedural success to PTCA but with a lower restenosis rate and better short- and intermediate-term outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: